Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Devil's claw (Harpagophytum procumbens) is a Southern African plant containing harpagoside, an iridoid glycoside that reduces inflammation and joint pain. It works by inhibiting inflammatory enzymes including cyclooxygenase-2 (COX-2) and lipoxygenase pathways.
Reported Benefits (Provisional)
Origin & History
Harpagophytum procumbens, commonly known as Devil's Claw, is a plant native to Southern Africa. It is traditionally harvested for its tuberous roots, which are used in various forms, such as teas and capsules.
Research Narrative (Provisional)
Research, including some randomized controlled trials, suggests Harpagophytum procumbens may be effective in reducing pain and inflammation, particularly in osteoarthritis and lower back pain.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Harpagophytum procumbens (Devil's Claw) is a medicinal root with limited conventional macronutrient significance but rich in bioactive compounds. Macronutrients per 100g dried root: carbohydrates approximately 47-52g (primarily as starch and oligosaccharides), protein approximately 4-6g, fat less than 1g, dietary fiber approximately 15-20g. Primary bioactive compounds: iridoid glycosides constitute 1-3% of dry weight, with harpagoside as the principal compound at 0.5-1.2% (standardized extracts often contain 1-2% harpagoside); harpagide at approximately 0.1-0.5%; procumbide at trace levels. Secondary metabolites include flavonoids (luteolin, kaempferol, quercetin derivatives) at approximately 0.5-1.0% dry weight; phenolic acids including caffeic acid and chlorogenic acid at 0.2-0.5%; phytosterols (beta-sitosterol, stigmasterol) at trace concentrations. Mineral content per 100g dried root: potassium approximately 800-1200mg, calcium approximately 50-80mg, magnesium approximately 30-50mg, iron approximately 5-8mg, zinc approximately 1-2mg. Vitamins are present in low amounts: vitamin C approximately 2-5mg/100g, small amounts of B-complex vitamins. Bioavailability notes: harpagoside bioavailability is enhanced when taken on an empty stomach; aqueous extracts demonstrate superior iridoid extraction compared to ethanolic preparations; gastric acid may partially hydrolyze iridoid glycosides, so enteric-coated formulations are sometimes recommended to improve systemic absorption.
Reported Mechanism (Provisional)
Harpagoside and other iridoid glycosides in devil's claw inhibit nuclear factor-kappa B (NF-κB) signaling, reducing production of inflammatory cytokines like TNF-alpha and interleukin-1β. The compounds also suppress cyclooxygenase-2 (COX-2) and 5-lipoxygenase enzymes, decreasing prostaglandin E2 and leukotriene synthesis. This dual pathway inhibition provides anti-inflammatory and analgesic effects particularly beneficial for joint conditions.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving 300-500 participants show devil's claw extract (containing 50-100mg harpagoside daily) significantly reduces osteoarthritis pain scores by 25-40% compared to placebo. A 4-month study of 122 patients found devil's claw as effective as diacerhein for knee osteoarthritis symptoms. However, most trials are small-scale and short-term, with limited data on long-term efficacy. Evidence is strongest for osteoarthritis and lower back pain, with moderate quality supporting anti-inflammatory effects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.